Is your microbiome making you sick?

Our gut bacteria can play a role in everything from sleep to IBS and how we deal with stress, and we are finally working out how to use them to improve our health.

In the last 10 years, interest in the microbiome – the vast colonies of bacteria and other organisms living in our digestive system – has intensified, including its possible role in gut complaints such as irritable bowel syndrome. Studies have shown that the faecal microbiota of people with IBS differs significantly from those of people who don’t have it. Some suggest that a course of antibiotics raises the risk of developing a functional gut disorder like IBS – another hint that an imbalance in gut bacteria might be involved.

 

4D Pharma plc (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    4d Pharma Plc

    More articles like this

    4d Pharma Plc

    People with fibromyalgia have different gut bacteria

    A study that compared women with and without fibromyalgia has, for the first time, linked gut bacteria to the long-lasting disease and its main symptoms. Researchers in Canada identified 19 species of gut bacteria that were present in

    4d Pharma Plc

    Findings link gut bacteria and Fibromyalgia

    Fibromyalgia affects 2-4 percent of the population and has no known cure. Symptoms include fatigue, impaired sleep, and cognitive difficulties, but the disease is most clearly characterized by widespread chronic pain. As reported in the journal Pain, approximately 20

    4d Pharma Plc

    Gut bacteria: The surprising impact of viruses

    The microbiome plays a vital role in health. A recent study has investigated how viruses that kill gut bacteria influence these microbes. The findings make an already complicated picture much more so. The microbiome is both fascinating and

    4d Pharma Plc

    4D pharma plc Presents MRx0518 combination study at ASCO

    4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced the presentation of a poster detailing its Phase I/II clinical study of MRx0518 combined with KEYTRUDA® in patients with solid tumours who